| Start date | Project | acronym | role | funding | partners |
|---|
| 2019-06-01 | Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs |
HARMONIC | participant | 6.999.989 | 24 |
| 2019-01-01 | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. |
ONCOBIOME | coordinator | 14.994.551 | 17 |
| 2018-01-01 | Randomized, Comparison Of Risk-Stratified versus Standard Breast Cancer Screening In European Women Aged 40-74 |
MyPEBS | participant | 12.436.859 | 23 |
| 2017-12-01 | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. |
CLINGLIO | participant | 6.155.125 | 12 |
| 2017-11-01 | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research |
SilkFUSION | participant | 2.998.500 | 6 |
| 2017-05-18 | ITCC Pediatric Preclinical POC Platform (ITCC-P4) |
ITCC-P4 | participant | 7.370.000 | 15 |
| 2016-12-01 | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors |
TKI resistance | participant | 1.500.000 | 1 |
| 2015-12-01 | Training Network for the Immunotherapy of Cancer |
IMMUTRAIN | participant | 3.627.525 | 9 |
| 2015-09-01 | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer |
ALKATRAS | participant | 3.849.200 | 23 |
| 2013-10-01 | EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma |
EEC | participant | 5.697.831 | 20 |
| 2013-06-01 | Mutanome Engineered RNA Immuno-Therapy |
MERIT | participant | 5.964.250 | 5 |
| 2013-03-01 | WINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patients |
WINTHER | coordinator | 2.998.355 | 11 |
| 2012-11-01 | Non-Invasive Optical Biopsy for Cancer Assessment using ultra high resolution Full-Field Optical Coherence Tomography |
CAReIOCA | participant | 3.099.481 | 5 |
| 2012-10-01 | Rational molecular Assessments and Innovative Drug Selection |
RAIDS | participant | 5.999.642 | 16 |
| 2012-09-01 | Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients |
CTCTRAP | participant | 6.000.000 | 12 |
| 2012-08-01 | Genetic epidemiological investigation into the association between endometriosis and cutaneous melanoma |
MELENDO2 | coordinator | 268.555 | 1 |
| 2012-04-01 | Biomaterials for Tracheal Replacement in Age-related Cancer via a Humanly Engineered Airway |
BIOtrachea | participant | 3.999.300 | 13 |
| 2012-02-01 | Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer |
RESPONSIFY | participant | 5.990.195 | 12 |
| 2011-12-01 | STRENGTHENING COOPERATION
IN MOLECULAR BIOMEDICINE BETWEEN EU AND UKRAINE |
COMBIOM | participant | 455.499 | 3 |
| 2011-12-01 | European Clinical trials in Rare Sarcomas within an integrated translational trial network |
EUROSARC | participant | 5.953.832 | 18 |
| 2011-10-01 | Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation |
PROCARDIO | participant | 2.998.387 | 13 |
| 2011-10-01 | Cognitive and Cerebrovascular Effects Induced by Low Dose Ionising Radiation |
CEREBRAD | participant | 2.999.517 | 12 |
| 2011-04-01 | Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE |
ARTFORCE | participant | 5.994.715 | 14 |
| 2011-02-01 | PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies |
PanCareSurFup | participant | 5.993.695 | 17 |
| 2011-01-01 | European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults |
ENS@T-CANCER | participant | 5.993.978 | 16 |
| 2011-01-01 | EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS |
ENCCA | participant | 11.997.959 | 34 |
| 2011-01-01 | Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics |
PREDICT | participant | 5.841.009 | 14 |
| 2011-01-01 | A European Platform for Translational Cancer Research |
EUROCANPLATFORM | participant | 11.998.454 | 28 |
| 2011-01-01 | Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis |
CURELUNG | participant | 2.965.749 | 11 |
| 2009-07-01 | Integrated micro-nano-opto fluidic systems for high-content diagnosis and studies of rare cancer cells |
CAMINEMS | participant | 3.551.143 | 9 |
| 2009-01-01 | Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies |
INFLA-CARE | participant | 11.999.889 | 22 |
| 2008-09-01 | Oral off-patent oncology drugs for kids |
03K | coordinator | 5.228.003 | 9 |
| 2008-09-01 | Prospective cohort studies of children with substantial medical diagnostic exposure |
CHILD-MED-RAD | participant | 279.931 | 9 |
| 2007-03-01 | Colon and breast cancer diagnostics |
COBRED | participant | 2.985.102 | 9 |
| 2007-02-01 | Molecular mechanisms underlying chemotherapy resistance, therapeutic escape, efficacy and toxicity |
CHEMORES | participant | 8.707.358 | 19 |
| 2006-11-01 | Selecting and validating drug targets from the human kinome for high risk pediatric cancers |
KIDSCANCERKINOME | coordinator | 3.415.414 | 11 |
| 2006-02-01 | CONnective TIssue CAncers NETwork to integrate European Experience in Adults and Children |
CONTICANET | participant | 9.432.600 | 21 |
| 2005-12-01 | European Prospective Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle |
EPIC | participant | 999.745 | 27 |
| 2005-12-01 | Genetic and environmental determinants of melanoma: translation into behavioural change |
GENOMEL | participant | 10.452.723 | 22 |
| 2005-10-01 | Feasibility Study for Coordination of National Cancer Research Activities |
EUROCAN+PLUS | participant | 3.000.000 | 17 |
| 2005-06-01 | Radiation exposures at an early age: impact of genotype on breast cancer risk |
GENE-RAD RISK | participant | 2.000.000 | 12 |
| 2005-01-01 | Dendritic cells for novel immmunotherapies |
DC-THERA | participant | 7.600.000 | 32 |
| 2004-07-01 | European Mantle Cell Lymphoma Network: Tranlational determination of molecular prognostic factors and pharmacogenomics in a European interdisciplinary collaboration |
EUROPEAN MCL NETWORK | participant | 2.493.900 | 18 |
| 2004-05-01 | METHODS AND ADVANCED EQUIPMENT FOR SIMULATION AND TREATMENT IN RADIO-ONCOLOGY |
MAESTRO | participant | 0 | 25 |
| 2004-03-01 | Molecular Imaging for Biologically Optimised Cancer Therapy |
BIOCARE | participant | 6.000.000 | 21 |
| 2004-03-01 | Translating molecular knowledge into early breast cancer management: building on the BIG (Breast International Group) network for improved treatment tailoring - TRANS-BIG |
TRANS-BIG | participant | 7.000.000 | 44 |
| 2004-01-01 | Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe |
EUROPEAN LEUKEMIANET | participant | 6.000.000 | 177 |
| 2003-01-01 | European standard operating procedures for electrochemotherapy and electrogenetherapy |
ESOPE | coordinator | 892.993 | 6 |
| 2002-12-01 | Interplay among mitochondria and p53 family proteins during apoptosis induced by dna damage - a new strategy for cancer therapy |
IMPALED | participant | 1.983.547 | 7 |
| 2002-11-01 | European society of paediatric oncology neuroblastoma research network |
SIOPEN-R-NET | participant | 1.891.932 | 18 |
European Research Ranking